Intravenous Immunoglobulin (IVIG) is a therapy treatment for patients with antibody deficiencies. It is prepared from a pool of immunoglobulins (antibodies) from the plasma of thousands of healthy donors. Immunoglobulins are made by the immune system of healthy people for the purpose of fighting infections. The intravenous immunoglobulin in United States market is expected to increase by USD 2.5 十亿, 以复合年增长率 (复合年增长率) 的 6.4% 从 2022 到 2028, according to the latest edition of the Intravenous Immunoglobulin Market in United States Report.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into intravenous immunoglobulin market in United States. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the intravenous immunoglobulin industry.

This industry report offers market estimates and forecasts of the United States market, 接下来是对应用的详细分析, and end user. The United States market for intravenous immunoglobulin can be segmented by application: chronic inflammatory demyelinating polyneuropathy (CIDP), chronic lymphocytic leukemia, congenital HIV/AIDS, guillain-barre syndrome (GBS), hypogammaglobulinemia, immune thrombocytopenic purpura (ITP), immunodeficiency diseases, kawasaki disease, multifocal motor neuropathy (MMN), myasthenia gravis, 其他的. The immunodeficiency diseases segment held the largest revenue share in 2021. Intravenous immunoglobulin market is further segmented by end user: homecare, 医院 & 诊所.

按申请:
– chronic inflammatory demyelinating polyneuropathy (CIDP)
– chronic lymphocytic leukemia
– congenital HIV/AIDS
– guillain-barre syndrome (GBS)
– hypogammaglobulinemia
– immune thrombocytopenic purpura (ITP)
– immunodeficiency diseases
– kawasaki disease
– multifocal motor neuropathy (MMN)
– myasthenia gravis
– 其他的

按最终用户:
– homecare
– 医院 & 诊所

The market research report covers the analysis of key stake holders of the intravenous immunoglobulin market in United States. Some of the leading players profiled in the report include ADMA Biologics Inc., Biotest AG, CSL Limited, Grifols, S.A., 约翰逊 & 约翰逊, Kedrion Biopharma Inc. (Kedrion SpA), LFB S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the intravenous immunoglobulin market in United States.
– To classify and forecast the intravenous immunoglobulin market in United States based on application, 最终用户.
– To identify drivers and challenges for the intravenous immunoglobulin market in United States.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the intravenous immunoglobulin market in United States.
– To identify and analyze the profile of leading players operating in the intravenous immunoglobulin market in United States.

为什么选择这份报告
– Gain a reliable outlook of the intravenous immunoglobulin market in United States forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.